Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Post-traumatic Inhibition of the Innate and Adaptive Immune System in the Development of Infectious Complications in Severely Injured Patients

NCT03489577 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT03489577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03489577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Post-traumatic Inhibition of the Innate and Adaptive Immune System in the Development of Infectious Complications in Severely Injured Patients
Lead sponsor
UMC Utrecht
Phase
Observational
Overall status
Terminated
Start date
June 30, 2014
Completion date
June 1, 2016
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disorder of neutrophils, innate immune response, multiple organ dysfunction syndrome, multiple trauma, sepsis